Selection of tumor antigens as targets for immune attack using immunohistochemistry: Protein antigens

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2669-2676

  Zhang, Shengle ^a   Zhang, Helen S ^a   Cordon Cardo, Carlos ^a   Ragupathi, Govindaswami ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; MUCIN; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; COLON CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR IMMUNOLOGY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; EPITHELIUM; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MUCINS; NEOPLASMS;

EID: 0031785581     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Zhang, S., Cordon-Cardo, C., Zhang, H. S., Reuter, V. E., Adluri, S., Hamilton, W. B., Lloyd, K. O., and Livingston, P. O. Selection of tumor antigens as targets for immune attack using immunohistochemistry. I. Focus on gangliosides. Int. J. Cancer, 73: 42-49, 1997.
2. Zhang, S., Zhang, H. S., Cordon-Cardo, C., Reuter, V. E., Singhal, A. K., Lloyd, K. O., and Livingston, P. O. Selection of tumor antigens as targets for immune attack using immunohistochemistry. II. Blood group-related antigens. Int. J. Cancer. 73: 50-56, 1997.
3. Robbins-Roth, C. Cancer vaccines: are we finally on the right track? Bioventure View. 12: 2-10, 1997.
4. Fair, W. R., Israeli, R. S., and Heston, W. D. W. Prostate-specific membrane antigen. Prostate, 32: 140-148, 1997.
5. Mclaughlin, J. P., Schlom, J., Kantor, J. A., and Greiner, J. W. Improved Immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2. Cancer Res., 56: 2361-2367, 1996.
6. Talwar, G. P., Singh, O., Pal, R., and Chatterjee, N. Vaccines for control of fertility and hormone dependent cancers. Int. J. Immunopharmacol., 14: 511-514, 1992.
7. Disis, M. L., Shiota, F. M., and Cheever, M. A. Human Her-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for "self" tumour antigens. Immunology, 93: 192-199, 1998.
8. Coussens, L., Yang-Feng, T. L., Chen, Y. L. E., Gray, A., Mcgrath, J., Seeburg, P. H., Liberman, T. A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. Tyrosine kinase receptor with extensive homology to egf receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230: 1132-1139, 1985.
9. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
10. Gendler, S., Lancaster, C., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E-N., and Wilson, D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem., 265: 15286-15293, 1990.
11. Jessup, J. M., and Thomas, P. Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma. Cancer Metastasis Rev., 8: 263-280, 1989.
12. Perez, M. S., and Walker, L. E. Isolation and characterization of a cDNA encoding the KS1/4 epithelial carcinoma marker 1. J. Immunol., 142: 3662-3667, 1989.
13. Bobek, L. A., Tsai, H., Biesbrock, A. R., and Levine, M. J. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem., 286: 20563-20569, 1993.
14. Dufosse, J., Porchet, N., Audie, J-P., Duperat, V. G., Laine, A., Van Seuningen, I., Marrakchi, S., Degand, P., and Aubert, J-P. Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human peptides mapped to 11p15. J. Biochem., 293: 329-337, 1993.
15. Duperat, V. G., Audie, J-P., Debailleul, V., Laine, A., Buisine, M-P., Galiegue-Zouitina, S., Pigny, P., Degand, P., Aubert, J-P., and Porchet, N. Biochemical characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes. Biochem. J., 305: 211-219, 1995.
16. Gum, J. R., Byrd, J. C, Hicks, J. W., Toribara, N. W., Lamport, D. T. A., and Kim, Y-S. Molecular cloning of human intestinal mucin cDNAs: sequence analysis and evidence for genetic polymorphism. J. Biol. Chem., 264: 6480-6487, 1989.
17. Gum, J. R., Hicks, J. W., Swallow, D. W., Legace, R. L., Byrd, J., Lamport, D. T., Siddiqui, B., and Kim, Y-S. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem. Biophys. Res. Commun., 171: 407-415, 1990.
18. Porchet, N., Nguyen, V. C., Dufosse, J., Audie, J. P., Guyonnet-Duperat, V., Gross, M. S., Denis, C., Degand, P., Bernheim, A., and Aubert, J. P. Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun., 175: 414-422, 1991.
19. Bellet, D., Lazar, V., Bleche, I., Paradis, V., Giovangrandi, Y., Paterlini, P., Lidereau, R., Bedossa, P., Bidart, J-M., and Vidaud, M. Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin B genes normally transcribed in trophoblastic cells. Cancer Res., 57: 516-523, 1997.
20. Apostolopoulos, V., Xing, P-X., and Mckenzie, I. F. C. Antipeptide monoclonal antibodies to intestinal mucin 3. J. Gastrol. Hepatol., 10: 555-561, 1995.
21. Byrd, J. C., Ho, J. J. L., Lamport, D. T. A., Ho, S. B., Siddiki, B., Huang, J., Yan, and Kim, Y. S. Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins. Cancer Res., 51: 1026-1033, 1991.
22. Carrato, C., Balague, C., De Bolos, C., Gonzalez, E., Gambus, G., Plana, J., Perini, J. M., Andreu, D., and Real, F. X. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 107: 160-172, 1994.
23. Dienhart, D. G., Schmelter, R. F., Lear, J. L., Miller, G. J., Glenn, S. D., Bloedow, D. C., Kasliwal, R., Moran, P., Seligman, P., Murphy, J. R., Kortright, K., and Bunn., P. A., Jr. Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigen. Cancer Res., 50: 7068-7076, 1990.
24. Ho, H. B., Niehans, G. A., Lyftogt, C., Yan, P. S., Cherwitz, D. L., Gum, E. T., Dahiya, R., and Kim, Y. S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
25. Hollingsworth, M. A., Strawhecker, J. M., Caffrey, T. C., and Mack, D. R. Expression of muc1, muc2, muc3 AND muc4 mucin mRNAs in human pancreatic and intestinal tumor cell lines. Int. J. Cancer. 57: 198-203, 1994.
26. Ichige, K., Percy, L., Vogel, C. A., Buchegger, F., and Kufe, D. Expression of the DF3-P epitope in human ovarian carcinomas. Clin. Cancer Res., 1: 565-571, 1995.
27. Reis, C. A., David, L., Nielsen, P. A., Clausen, H., Mirgorodskaya, K., Roepstprff, P., and Sobrinho-Simoes, M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int. J. Cancer, 74: 112-121, 1997.
28. Silver, D. A., Pellicer. I., Fair, W. R., Heston, W. D. W., and Cordon-Cardo, C. Prostate specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res., 3: 81-85, 1997.
29. Yu, C-J., Yang, P-C., Shun, C-T., Lee, Y-C., Kuo, S-H., and Luh, K-T. Overexpression of MUC5 genes is associated with early postoperative metastasis in non-small-cell lung cancer. Int. J. Cancer. 69: 457-465, 1996.
30. Livingston, P. O., and Ragupathi, G. Carbohydrate vaccines that induce antibodies against cancer. Part II: Previous experience and future plans. Cancer Immunol. Immunother., 45: 10-19, 1997.
31. Livingston, P. O., Wong, G. Y. C., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., M. J., Helling, F., Ritter, G., Oettgen, H. F., and Old, L. J. Improved survival in AJCC stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside, J. Clin. Oncol., 12: 1036-1044, 1994.
32. MacLean, G. D., Reddish, M. A., Koganty, R. R., and Longenecker, B. M. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic sTn vaccine. J. Immunol., 19: 59-68, 1996.
33. Hsu, S. M., Rain, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
34. Dippold, W. G., Lloyd, K. O., Li, L. T., Ikeda, H., Oettgen, H. F., and Old, L. J. Cell-surface antigens of human malignant melanoma: definition of six antigenic systems with monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 77: 6114-6118, 1980.
35. Thompson, J. A., Grunert, F., and Zimmerman, W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal., 5: 344-366, 1991.
36. Zhang, S., Zhang, H. S., Reuter, V. E., Lloyd, K. O., Scher, H., and Livingston, P. O. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin. Cancer Res., 4: 295-302, 1998.
37. Gambus, G., Bolos, C. D., Andreu, D., Franci, C., Egea, G., and Real, F. X. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology, 104: 93-102, 1993.
38. Gottlinger, H. G., Funke, I., Johnson, J. P., Gokel, J. M. M., and Riethmuller, G. The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer. 38: 47-53, 1986.
39. Hayes, D. F., Zurawski, V. R., and Kufe, D. W. Comparison of circulating CA15-and carcinoembryonic antigen levels in patients with breast cancer. J. Clin. Oncol., 4: 1542-1550, 1986.
40. r 110,000 gene product in human gastric carcinoma cells that is immunologically related to carcinoembryonic antigen. Cancer Res., 51: 5694-5703, 1991.
41. Taylor-Papadimitriou, J., Peterson, J. A., Arklie, J., Burchell, J., Ceriani, R., and Bodmer, W. F. Monoclonal antibodies to epithelium specific components of the milk fat globule membrane: production and reactions with cells in culture. Int. J. Cancer, 28: 17-21, 1981.
42. Gendler, S. J., Spicer, A. P., Lalani, E-N., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Boshell, M., and Taylor-Papadimitriou, J. Structure and biology of a carcinoma associated mucin, MUC1. Am. Rev. Respir. Dis., 144 (Suppl.): s42-s47, 1991.
43. Xing, P. X., Prenzoska, J., Apostolopoulos, V., Karkaloutsos, J., and McKenzie, I. F. C. Monoclonal antibodies to MUC4 peptide react with lung cancer. Int. J. Oncol. 11: 289-295, 1997.
44. Nielsen, P. A., Mandel, U., Therkildsen, M. H., and Clausen, H. Differential expression of human high molecular weight salivary mucin (MG1) and low molecular weight salivary mucin (MG2). J. Dental Res., 75: 1820-1826, 1996.
45. Nielsen, P. A., Bennett, E. P., Wandall, H. H., Therkildsen, M., Hannibal, J., and Clausen, H. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B. Glycobiology. 7: 413-419, 1997.
46. Heston, D. W. Biologic implications for prostatic function following identification of prostate-specific membrane antigen as a novel folate hydrolase/neurocarboxypeptidase. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 267-294. New York: CRC Press, 1997.
47. Herlyn, D., Herlyn, M., Ross, A. H., Ernst, C., Atkinson, B., and Koprowski, H. Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J. Immunol. Methods. 73: 157-167, 1984.
48. Bellet, D. H., Ozturk, M. Bidart, J. M., Bouhuon, C. J., and Wands, J. R. Sensitive and specific assay for human chorionic gonadotropin (hCG) based on anti-peptide and anti-hCG monoclonal antibodies: construction and clinical implications. J. Clin. Endocrinol. Metab., 63: 1319-1326, 1986.